Kenai Therapeutics

Kenai Therapeutics is a biotechnology company pioneering the next generation of treatments for neurological disorders. The company leverages allogeneic induced pluripotent stem cell (iPSC) technology, a Nobel Prize-winning breakthrough that enables scientists to create various human cell types to advance Kenai's off-the-shelf neuronal replacement therapies. By focusing on the iPSC technology platform and establishing partnerships with global leaders in surgical procedures and clinical development, Kenai is committed to advancing a first-in-class pipeline targeting neurological diseases.